Breastfeeding, also known as chestfeeding, provides immense benefits to the infant, including protection against leukemia, or ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

“Softer shades of pink are perceived to be more delicate than red, evoking feelings of youthful sweetness, while the brighter ...

Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

In India, sex education has often been seen as a taboo subject. However, it should go beyond just preventing infections and ...

Concern over "anti-nutrients" in fruits and vegetables is growing on social media, but do you really have to fear these plant compounds? Here's what experts have to say.

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase ...